Healio They assessed for treatment with broad-spectrum antimicrobials — third-generation cephalosporins with or without macrolide — and narrow-spectrum antimicrobials — aminopenicillins with or without macrolide — within the first 2 days of hospital stay.
GlobeNewswire (press release) The company also intends to use its series of proprietary lead compounds from its novel macrolide library for uses such as the treatment of chronic inflammatory diseases, endocrine diseases and gastric motility disorders. Additional information about ...
Stock Market Wire Aivlosin, Eco's patented macrolide antibiotic, is used for the treatment of a variety of economically important respiratory and enteric (gut) diseases in pigs and poultry. Chairman Peter Lawrence said: "This positive opinion from the EMA is a further ...
Business Wire (press release) Aivlosin®, ECO's patented macrolide antibiotic, is used for the treatment of a variety of economically important respiratory and enteric (gut) diseases in pigs and poultry. Peter Lawrence, Chairman, commented “This positive opinion from the EMA is a ... and more »
4-traders (press release) Omeclamox-Pak is contraindicated in patients with a history of hypersensitivity to omeprazole, any macrolide antibiotic or penicillin. The safety and effectiveness of Omeclamox-Pak in the pediatric population has not yet been established. Omeclamox-Pak ... and more »
GlobeNewswire (press release) The company also intends to use its series of proprietary lead compounds from its novel macrolide library for uses such as the treatment of chronic inflammatory diseases, endocrine diseases and gastric motility disorders. Additional information about ...
4-traders (press release) Both seek to address the need for new treatments targeting drug-resistant bacterial infections in the hospital and in the community. The company also intends to use its series of proprietary lead compounds from its novel macrolide library for uses such ...
GlobeNewswire (press release) The company also intends to use its series of proprietary lead compounds from its novel macrolide library for uses such as the treatment of chronic inflammatory diseases, endocrine diseases and gastric motility disorders. Additional information about ...
GlobeNewswire (press release) The company also intends to use its series of proprietary lead compounds from its novel macrolide library for uses such as the treatment of chronic inflammatory diseases, endocrine diseases and gastric motility disorders. Additional information about ...
4-traders (press release) The company also intends to use its series of proprietary lead compounds from its novel macrolide library for uses such as the treatment of chronic inflammatory diseases, endocrine diseases and gastric motility disorders. Additional information about ... and more »
